Kapitalo Investimentos Ltda Biomarin Pharmaceutical Inc Transaction History

Kapitalo Investimentos Ltda

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Mar 29, 2024	SELL	$86.68 - $100.3 $287,084 - $332,193	-3,312 Closed	0 $0
Q1 2023 Mar 29, 2024	BUY	$87.74 - $117.27 $250,234 - $334,454	2,852 Added 620.0%	3,312 $322 Million
Q4 2022 Mar 29, 2024	BUY	$80.93 - $108.63 $37,227 - $49,969	460 New	460 $47.6 Million

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.